Canada markets close in 2 hours 48 minutes

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
7.39+0.01 (+0.20%)
As of 01:11PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close7.38
Open7.37
Bid7.38 x 800
Ask7.42 x 800
Day's Range7.26 - 7.63
52 Week Range4.00 - 10.24
Volume108,655
Avg. Volume257,204
Market Cap220.249M
Beta (5Y Monthly)0.20
PE Ratio (TTM)N/A
EPS (TTM)-1.71
Earnings DateAug 12, 2024 - Aug 16, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.40
  • Zacks

    Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?

    Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.

  • Newsfile

    Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions

    Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 18, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring Actinium Pharmaceuticals, Inc. (NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies.Read the full article on Inve

  • Newsfile

    Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML)

    Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 17, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the companies developing innovative solutions, featuring Actinium Pharmaceuticals, Inc. (NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targ